secwatch.observer — SEC 8-K summary
======================================

Issuer:     DENTSPLY SIRONA Inc. (XRAY)
CIK:        0000818479
Form:       8-K
Filed at:   2022-08-25T23:59:59+00:00
Accession:  0000818479-22-000089
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dentsply Sirona appoints Simon Campion (ex-BD) as CEO, effective Sept 12, 2022
------------------------------------------------------------------------------

- Simon Campion appointed President & CEO, effective Sept 12, 2022; succeeds interim CEO John Groetelaars who remains on Board.
- Campion previously EVP & President of BD Medical segment; held leadership roles at BD and C.R. Bard.
- Board requests full review of business operations including competitive positioning, margin enhancement, and capital structure.
- Employment agreement: $1M base salary, 125% target bonus, $7M equity make-whole grant, annual LTI of at least $5M starting FY2023.
- Ongoing Audit Committee review mentioned; new CEO to lead after completion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818479/000081847922000089/0000818479-22-000089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818479/000081847922000089/xray-20220822.htm
  HTML page:      https://secwatch.observer/filing/0000818479-22-000089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer